“Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?”, Bleeding Thromb Vascul Biol, vol. 2, no. 3, Aug. 2023, doi: 10.4081/btvb.2023.90.